Published guidance, NICE advice and quality standards | Guidance

Showing 1621 to 1630 of 2417

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer	TA737	20 October 2021	29 August 2024
Pembrolizumab with trastuzumab and chemotherapy for untreated locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction adenocarcinoma	TA983	12 June 2024	12 June 2024
Pemetrexed for the first-line treatment of non-small-cell lung cancer	TA181	23 September 2009	23 September 2009
Pemetrexed for the maintenance treatment of non-small-cell lung cancer	TA190	23 June 2010	10 August 2017
Pemetrexed for the treatment of malignant pleural mesothelioma	TA135	23 January 2008	23 January 2008
Pemetrexed for the treatment of non-small-cell lung cancer	TA124	22 August 2007	22 August 2007
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin	TA402	24 August 2016	24 August 2016
Pemigatinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangement	TA722	25 August 2021	25 August 2021
Pentosan polysulfate sodium for treating bladder pain syndrome	TA610	13 November 2019	13 November 2019
People's experience in adult social care services: improving the experience of care and support for people using adult social care services	NG86	20 February 2018	20 February 2018